Nutex Health (US:NUTX) Prnewswireยท2025-05-13 21:43Core Viewpoint - Nutex Health Inc. reported strong financial results for Q1 2025, showcasing significant growth in revenue, net income, and operational efficiency, driven by increased hospital visits and successful arbitration efforts [4][6]. Financial Performance - Total revenue for Q1 2025 reached $211.8 million, a 213.8% increase from $67.5 million in Q1 2024 [9]. - Net income attributable to Nutex Health was $14.6 million, compared to a net loss of $0.4 million in Q1 2024 [9]. - Diluted earnings per share (EPS) improved to $2.56 from $(0.08) in Q1 2024 [9]. - EBITDA for Q1 2025 was $43.1 million, a 507.0% increase from $7.1 million in Q1 2024 [9]. - Adjusted EBITDA was $72.8 million, compared to $(0.4) million in Q1 2024 [9]. Operational Highlights - Total hospital division visits increased by 20.5% to 48,269 in Q1 2025, up from 40,068 in Q1 2024 [9]. - Revenue from mature hospitals rose by 186.5% in 2025 compared to 2024 [9]. - The arbitration process contributed approximately $105.0 million in additional revenue, accounting for 73.1% of the total revenue increase [9]. Cash Flow and Balance Sheet - Net cash from operating activities was $51.0 million for Q1 2025 [9]. - As of March 31, 2025, total assets were $761.9 million, with cash and cash equivalents of $87.7 million [10]. - Long-term debt stood at $21.7 million [10]. Stock-Based Compensation - Total stock-based compensation expense for Q1 2025 was $36.1 million, significantly higher than less than $0.1 million in Q1 2024 [9].